181 related articles for article (PubMed ID: 20618287)
1. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians.
Wang Z; Hoy WE
Aust N Z J Public Health; 2010 Jul; 34 Suppl 1():S25-9. PubMed ID: 20618287
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians.
Wang Z; Hoy WE
Diabetes Res Clin Pract; 2007 Apr; 76(1):37-43. PubMed ID: 16952410
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
[TBL] [Abstract][Full Text] [Related]
5. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
[TBL] [Abstract][Full Text] [Related]
7. Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people.
Wang Z; Hoy WE
Eur J Clin Nutr; 2004 Jun; 58(6):888-93. PubMed ID: 15164109
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population.
Jiang S; Bao Y; Hou X; Fang Q; Wang C; Pan J; Zuo Y; Zhong W; Xiang K; Jia W
Am J Cardiol; 2009 Jun; 103(12):1727-31. PubMed ID: 19539083
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
11. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia.
Shemesh T; Rowley KG; Jenkins A; Brimblecombe J; Best JD; O'Dea K
Int J Obes (Lond); 2007 Jan; 31(1):103-8. PubMed ID: 16682979
[TBL] [Abstract][Full Text] [Related]
12. Population distribution of high sensitivity C-reactive protein values in Aboriginal Australians: a comparison with other populations.
Wang Z; Hoy WE
Clin Biochem; 2006 Mar; 39(3):277-81. PubMed ID: 16405882
[TBL] [Abstract][Full Text] [Related]
13. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
14. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Albert MA; Glynn RJ; Buring J; Ridker PM
Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
17. Inflammation biomarkers and near-term death in older men.
Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
[TBL] [Abstract][Full Text] [Related]
18. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
19. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
20. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.
Romero-Corral A; Sierra-Johnson J; Lopez-Jimenez F; Thomas RJ; Singh P; Hoffmann M; Okcay A; Korinek J; Wolk R; Somers VK
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):418-25. PubMed ID: 18431365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
